© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 08, 2021
Letters to legislators call for increased funding to address ongoing crisis.
March 26, 2021
Spero Therapeutics expects to submit a new drug application this year for Tebipenem HBr, the first oral carbapenem for treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP).
March 23, 2021
Filmmaker Bill Mudge has released his new documentary, Beating Superbugs: Can We Win? It looks at emerging technologies designed to develop new therapies to combat antibiotic resistance (ABR).
March 19, 2021
New drugs likely won’t meet resistance challenges ahead, authors say.
March 16, 2021
Melinta Therapeutics’ oritavancin therapy is indicated for treatment of acute bacterial skin and skin structure infections (ABSSSI) in adult patients.
March 07, 2021
While the world’s focus remains on COVID-19, beyond this ongoing crisis lingers another that requires leadership, innovation, and collaboration from policy makers, the health care community, and the private sector.
February 12, 2021
February 11, 2021
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
February 10, 2021
An assessment of a comparative study between leading options for a burdensome infection.
November 27, 2020
The IDSA representative discusses advances made in recent years, and how foundational guidance could be set by the FDA with input from specialists.